Timigutuzumab

Modify Date: 2024-04-08 18:13:46

Use of Timigutuzumab

Timigutuzumab (GEXMab73) is a humanized monoclonal antibody that targets ErbB2. Timigutuzumab can be used for the research of cancer[1].

Name	Timigutuzumab

Description	Timigutuzumab (GEXMab73) is a humanized monoclonal antibody that targets ErbB2. Timigutuzumab can be used for the research of cancer[1].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> JAK/STAT Signaling >> EGFR Signaling Pathways >> Protein Tyrosine Kinase/RTK >> EGFR
In Vitro	Timigutuzumab 经过糖优化，可增强抗体依赖性细胞介导的细胞毒性[1]。
References	[1]. Santis RD. Anti-ErbB2 immunotherapeutics: struggling to make better antibodies for cancer therapy. MAbs. 2020 Jan-Dec;12(1):1725346.

No Any Chemical & Physical Properties